ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2013

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

H Tedeholm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.